Xenoport (MM)
   
To register click here

Xenoport Stock Price XNPT

Company Description : A biopharmaceutical Company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transport mechanisms to improve the therapeutic benefits of existing drugs. url: www.xenoport.com

Name:
Xenoport (MM)
Symbol:
NASDAQ:XNPT
Stock Market:
NASDAQ Stock Market
Type:
Common Stock
ISIN:
Description:
 Change (p)Change (%)CurBidAskHighLowOpenVolumeTimeA
1.292.9545.0943.5545.8545.2143.844.1924209317:00:00
To register Click hereRegister for free Xenoport stock prices.

Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Sever : Additional Data Demonstrate Predictable, Extended Exposure with Sustained- Release Formulation CHICAGO, April 17 /PRNewswire/ -- Data from the first pivotal study of XP13512/GSK1838262, a sustained-release investigational...

Free Xenoport Stock Charts

Xenoport Historical Stock Chart
Xenoport Historical Stock Chart
Xenoport Monthly Stock Chart
Xenoport Monthly Stock Chart
Xenoport Intraday stock chart
Xenoport Intraday stock chart

To register Click hereRegister for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range.

Get the Latest Xenoport stock Price, quotes, trades and FREE Xenoport stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Xenoport (XNPT) and other NASDAQ Stock Market listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards.

Xenoport News

Latest Xenoport News Headlines
DateTimeSource
Headline
04/17/20083:15PMPRNUSData Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Sever
03/12/20089:00AMTFNFXenoPort: positive results in Phase I trial of Parkinson's disease drug XP21279
03/12/20089:00AMTFNFXenoPort: postive results in Phase I trial of Parkinson's disease drug, XP21279
02/14/20086:01PMTFNFXenoPort 4Q profit above Street view; company sees losses ahead
01/15/20088:37AMTFNFXenoPort reports positive results in restless legs syndrome drug trial
11/07/20075:28PMTFNFXenoPort swings to profit on collaboration with GSK, Astellas, sees losses ahead

Xenoport Company Information

 Sector  Turnover (m)  Profit (m)  EPS - Basic  PE ratio  Mkt Cap (m)  NMS 
  0.00 0.00   0.0 N/A
To register Click hereRegister for FREE access to the latest Xenoport company information and fundamental data for other USA Common Stock companies. More than 100 separate statistics including accounts payable / sales and inventory / sales.

Latest Xenoport Stock Trade

 Type  Size  Price  Date  Tr.Time  Units 
  200 45.09 07/25/2008 4:35PM USD


 



PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
33 site:2us nasdaq xnpt080725 18:09 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )